The Polish legal system has recently undergone a number of significant changes, the most recent of which concern the Code of Civil Procedure. A few years ago, conducting an online hearing was impossible. Although the regulations allowed videoconferencing, it was limited to connections between courts, mainly used for questioning witnesses. The COVID-19 pandemic has significantly affected these regulations, leading to the introduction of the possibility of remote participation in hearings. Thanks to the amendment of the regulations in March 2020, remote hearings have become a reality, initially as a temporary solution, aimed at counteracting the effects of the pandemic.
Seeing the effectiveness and convenience of remote hearings, the legislator decided to permanently introduce this form to the Code of Civil Procedure. On March 14, 2024, an amendment came into force, which not only consolidates remote hearings as a standard procedure, but also introduces a number of other innovations. The aim of these changes is to streamline and accelerate civil proceedings, so that the justice system is more effective and accessible to citizens and entrepreneurs.
Artificial intelligence is an invention that is definitely changing the world. One of the most interesting areas of its use is the medical industry. Soon, all pharmaceuticals discovered and produced using AI will be available in pharmacies. This industry is also associated with the use of artificial intelligence for medical products. On the one hand, it is about using it for clinical trials on a specific product, i.e. taking advantage of the AI program to introduce this product to the market faster. On the other hand, it is about authorizing a specific medical product whose operation will be based on the use of AI.
The government’s draft law on artificial intelligence systems “serves to apply Regulation (EU) 2024/1689 of the European Parliament and of the Council of 13 June 2024 on the establishment of harmonised rules on artificial intelligence [1]“, also known as the AI Act . This document defines the principles of supervision of the market of artificial intelligence systems and the AI model and covers the organisation of supervision, the conditions for accreditation of conformity assessment bodies, incident reporting and the imposition of administrative penalties for the use of prohibited practices under Article 5 of the European Regulation on artificial intelligence. Moreover, this draft is to be applied, among others, to persons located in the EU affected by AI, importers and distributors of AI systems, entities using AI systems that are established or located in the Union, and suppliers introducing AI systems to the market or putting them into service [2]. Additionally, the act provides for the creation of the Office of the Commission for the Development and Security of Artificial Intelligence, which is a state legal person [3].
What is the Artificial Intelligence Development and Security Commission?
The Human Cell Atlas (HCA) is a groundbreaking global initiative aimed at mapping all human cell types to transform our understanding of health and disease. By creating a detailed reference map of human cells, the HCA is poised to advance medical research, enabling better disease diagnosis, treatment, and prevention. Using cutting-edge technologies like single-cell genomics and spatial analysis, the project is generating vast amounts of data, with global participation from over 3,200 scientists across 99 countries. The HCA’s findings have significant medical implications, including insights into disease mechanisms, personalized therapies, and rapid responses to health crises like the COVID-19 pandemic. Despite its vast potential, the HCA faces challenges, particularly in ensuring global equity and navigating complex ethical and legal issues like data protection and intellectual property. Efforts to create an inclusive, diverse, and open data-sharing platform are crucial, but disparities in infrastructure and knowledge between high-income and low- to middle-income countries remain barriers. Addressing these challenges with robust ethical frameworks, data protection measures, and clear intellectual property guidelines is essential to the HCA’s success. Ultimately, the HCA aims to provide a transformative resource that enhances human health while fostering global collaboration and inclusivity.
On December 5, 2024, KIELTYKA GLADKOWSKI KG Legal joined the Polish-Tunisian Economic Forum in Warsaw, an event aimed at encouraging business partnerships and strengthening economic ties between the two countries. The forum was organized by the Polish National Chamber of Commerce, CONECT International, and the Tunisian Embassy in Poland, with support from the Polish Embassy in Tunis and PAIH SA.
